secwatch.observer — SEC 8-K summary
======================================

Issuer:     AYTU BIOPHARMA, INC (AYTU)
CIK:        0001385818
Form:       8-K
Filed at:   2022-12-13T23:59:59+00:00
Accession:  0001558370-22-018607
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aytu BioPharma dismisses Plante & Moran, appoints Grant Thornton as auditor
---------------------------------------------------------------------------

- Dismissed Plante & Moran on Dec 12, 2022; reports had no adverse opinions but FY2022 included going concern explanatory paragraph.
- Appointed Grant Thornton LLP as independent auditor for fiscal year 2023.
- No disagreements on accounting principles; material weakness in impairment analysis previously reported and remediated.
- Grant Thornton had not been consulted on any accounting matters prior to engagement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1385818/000155837022018607/0001558370-22-018607-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1385818/000155837022018607/aytu-20221212x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-018607

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer